Vasade Biosciences Inc.

Barnegat Light, NJ Vatner

UEI
J66DCHJSKWA4
CAGE
46YB1
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
16 E 27th St, Barnegat Light, NJ 08006, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
A novel pharmacological inhibitor of adenylyl cyclase type 5 to treat alzheimer's disease R41AG080990 National Institute on Aging (NIH) $756,390
Adenylyl cyclase type 5 inhibition to treat myocardial infarction R44HL142390 National Heart Lung and Blood Institute (NIH) $1,495,601
Acute coronary syndrome animal model R43HL116052 National Institutes of Health $167,930
AC5 inhibitor for heart failure R44HL112512 National Institutes of Health $1,826,654
Antimir-199A for cardiac ischemia and failure R43HL103026 National Institutes of Health $132,191

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Vasade Biosciences Inc. registered in SAM.gov?

Yes. Vasade Biosciences Inc.'s SAM.gov registration is active through August 6, 2027.

What is Vasade Biosciences Inc.'s most recent federal award?

Vasade Biosciences Inc.'s most recent federal grant award is A novel pharmacological inhibitor of adenylyl cyclase type 5 to treat alzheimer's disease (R41AG080990), from National Institute on Aging (NIH), on December 1, 2022.

On GovTribe

See Vasade Biosciences Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login